Press release
Elevate Pharmaceutical R&D with Aquigen BioSciences' Precision‐Grade Flibanserin Impurity B: Custom Synthesis, Unmatched Purity, ANDA‐Ready Reference Standard to Drive Analytical Method Development and Regulatory Compliance
Flibanserin Impurity B is a reference standard used in pharmaceutical research and development. It is primarily applied during the analysis and validation of drug substances to identify, quantify, and control impurities that may be present in the final product. This impurity is associated with the parent compound, Flibanserin, a medication approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.Aquigen BioSciences offers Flibanserin Impurity B as a part of its impurity standards product line, which supports regulatory filings, such as Abbreviated New Drug Applications (ANDAs), method development, and quality control processes.
Explore Flibanserin Impurity B
https://aquigenbio.com/product/flibanserin-impurity-b/
Product Details
Product Name: Flibanserin Impurity B
Catalog No.: AQ-F004811
Molecular Formula: C21H24N4O3
Molecular Weight: 380.5
Application: For analytical use only. Not intended for human consumption.
Availability: Currently available on backorder.
COA & Documentation: Certificate of Analysis available for download from the product page.
Usage and Applications
Flibanserin Impurity B is used in pharmaceutical laboratories during:
Impurity Profiling: Detecting and identifying trace-level impurities in the Flibanserin active pharmaceutical ingredient (API).
Analytical Method Development: Developing and validating analytical methods for drug testing.
Stability Testing: Studying how impurities form over time in storage or under stress conditions.
Quality Control: Ensuring that impurity levels are within acceptable regulatory limits.
The impurity standard allows manufacturers to establish specifications and meet requirements from regulatory authorities such as the US FDA or EMA during drug approval processes.
Storage and Handling
As with all chemical reference standards, Flibanserin Impurity B must be handled with proper safety precautions. It is intended for use by trained laboratory professionals in controlled environments.
Key points for handling:
Use appropriate personal protective equipment (PPE).
Store in a cool, dry place, away from direct sunlight and incompatible substances.
Follow laboratory safety protocols for storage and disposal.
Refer to the Safety Data Sheet (SDS) for detailed safety and handling instructions.
Flibanserin Impurity C
https://aquigenbio.com/product/flibanserin-impurity-c/
Another impurity standard offered in this series is Flibanserin Impurity C, which is also used in similar analytical workflows.
Product Details
Product Name: Flibanserin Impurity C
Catalog No.: AQ-F004812
Molecular Formula: C20H22N4O3
Molecular Weight: 366.4
Application: Analytical reference standard. Not for human use.
Flibanserin Impurity C supports broader impurity profiling and is useful in situations where multiple impurity markers are analyzed simultaneously. This helps ensure the robustness and accuracy of the analytical method.
Flibanserin Impurity Standards - Product Category
Aquigen BioSciences provides a full range of impurity standards related to Flibanserin. These impurities are used by pharmaceutical labs and contract research organizations (CROs) worldwide for ensuring that drug formulations meet required safety and efficacy criteria.
The category includes:
Impurity reference standards for drug substances
Custom synthesis options for unavailable or rare impurities
Products available with full documentation, including Certificate of Analysis and SDS
Explore the full category here:
https://aquigenbio.com/products/impurity-standards/fibanserin/
Key Benefits of Using Flibanserin Impurity Standards
Regulatory Compliance: Supports data required for ANDA submissions and other regulatory filings.
Analytical Accuracy: Enables precise identification and quantification of impurities.
Consistency: Manufactured under controlled conditions to ensure batch-to-batch consistency.
Documentation: Comes with COA, SDS, and other essential quality documents.
Custom Synthesis Options: Available upon request if standard is on backorder or requires specific modifications.
Ordering and Custom Requests
Flibanserin Impurity B is available for ordering through Aquigen BioSciences' website. While currently listed as on backorder, customers can request synthesis or inquire about lead time directly through the product page.
For bulk orders, documentation requests, or technical inquiries, users can contact the Aquigen team through the contact form available on the website.
Safety and Legal Disclaimer
All products, including Flibanserin Impurity B and Flibanserin Impurity C, are:
Supplied for laboratory and research use only.
Not intended for human or veterinary use.
To be used only by qualified professionals in a lab environment.
Please consult the Certificate of Analysis and SDS before using the product.
Summary
Flibanserin Impurity B is an essential reference standard used in pharmaceutical development and regulatory testing related to Flibanserin drug substances. It is a valuable component of impurity profiling, method validation, and quality assurance workflows. Alongside related products like Flibanserin Impurity C, it offers comprehensive support for pharmaceutical R&D and manufacturing processes.
Contact:
Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Phone: +91 7030123794
Email: bd@aquigenbio.com
Visit: www.aquigenbio.com
About Aquigen Bio Sciences
Aquigen Bio Sciences is at the forefront of pharmaceutical excellence, serving as the leading resource for Flibanserin Impurity standards in India. With a strong commitment to safety, innovation, and regulatory compliance, the organization specializes in impurity profiling, synthesis, and analysis, empowering pharmaceutical manufacturers globally with premier standards. Aquigen Bio Sciences' dedication to cutting-edge research ensures it remains a trusted partner in refining quality benchmarks across the pharmaceutical landscape.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Elevate Pharmaceutical R&D with Aquigen BioSciences' Precision‐Grade Flibanserin Impurity B: Custom Synthesis, Unmatched Purity, ANDA‐Ready Reference Standard to Drive Analytical Method Development and Regulatory Compliance here
News-ID: 4165416 • Views: …
More Releases from Aquigen Bio Sciences

Estradiol Valerate EP Impurity A - Premium Reference Standard for Analytical Dev …
Estradiol Valerate EP Impurity A is a high-quality reference standard designed to meet the stringent requirements of pharmaceutical research, method validation, and quality control processes.
Explore Estradiol Valerate EP Impurity A :
https://aquigenbio.com/product/estradiol-valerate-ep-impurity-a/
Manufactured and characterized with precision, this impurity standard supports laboratories and manufacturers in achieving consistent, reliable, and reproducible results in critical analytical workflows.
With its exceptional purity and accurate characterization, Estradiol Valerate EP Impurity A plays a vital role…

High-Purity N-Nitroso Betahistine D3 for Precise Pharmaceutical Analysis | Deute …
Product Overview
N-Nitroso Betahistine D3 is a premium deuterated nitrosamine impurity standard, specifically developed for precise analytical testing in pharmaceutical laboratories. This reference standard is widely used for analytical method development, validation, and quality control processes to meet stringent regulatory guidelines. With exceptional purity, complete documentation, and reliable traceability, it is ideal for research, development, and compliance applications.
https://aquigenbio.com/product/n-nitroso-betahistine-d3/
Key Features and Benefits
Deuterated Design for Precision: The incorporation of deuterium improves mass spectrometric…

Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impur …
Aquigen Bio, a trusted supplier of pharmaceutical reference standards, today announced the expansion of its Icatibant Impurity Standards portfolio, designed to support drug developers, analytical laboratories, and research organizations with reliable materials for impurity profiling and quality control.
Icatibant, a selective bradykinin B2 receptor antagonist, is widely used in the treatment of hereditary angioedema (HAE). Given its peptide-based structure, Icatibant is prone to the formation of impurities during synthesis and storage.…

Elevating Analytical Precision with Harmine Impurity Standards
In the realm of pharmaceutical research, controlling the purity of compounds is pivotal. When evaluating psychoactive alkaloids such as harmine-a β-carboline alkaloid known for its reversible monoamine oxidase A inhibition and emerging therapeutic potential-accuracy is non-negotiable. This is where Aquigen Bio Sciences brings its edge: supplying high-grade impurity standards to underpin analytical consistency and regulatory compliance.
Why Harmine Impurity Standards Matter
https://aquigenbio.com/products/impurity-standards/harmine/
Harmine occurs naturally in Peganum harmala and Banisteriopsis caapi, and has…
More Releases for Flibanserin
Best Female Arousal Pills Incredible Impact On Female Testosterone Booster!
About Best Female Arousal
Female Arousal, regularly alluded to as medications and supplements aimed at enhancing female Lust function, addresses various issues such as low, arousal difficulties, and overall Lust satisfaction. Unlike the male Arousal, which primarily works by increasing blood stream, female Lust enhancement pills often work on different mechanisms, including hormonal balance, temperament enhancement, and increased sensitivity.
OFFICIAL WEBSITE:- bit.ly/3KzAkHq
What is the Best Medicine for Intercourse (for a Female)?
The best…
Retinol Propionate Market Riding the Wave: Market Players Exploiting Growth Aven …
"This comprehensive Retinol Propionate report offers a deep dive into the global market, encompassing a wide spectrum of analyses to equip you with a profound understanding of its dynamics. Beyond the standard SWOT analysis, our study incorporates a diverse range of analytical approaches, including the insightful PESTLE analysis, qualitative and quantitative assessments, absolute dollar opportunity analysis, and the robust Porter's Five Forces analysis. We leave no stone unturned when exploring…
Vitamin A Propionate Market Thriving in Growth Zones: High-Potential Segments' S …
"This comprehensive Vitamin A Propionate report offers a deep dive into the global market, encompassing a wide spectrum of analyses to equip you with a profound understanding of its dynamics. Beyond the standard SWOT analysis, our study incorporates a diverse range of analytical approaches, including the insightful PESTLE analysis, qualitative and quantitative assessments, absolute dollar opportunity analysis, and the robust Porter's Five Forces analysis. We leave no stone unturned when…
Female Hypoactive Sexual Desire Disorder Therapeutics Market Covid-19 Impact Ana …
Hypoactive sexual desire disorder (HSDD) is sexual dysfunction. It is defined as a lack or absence of sexual fantasies and desire for sexual activity. It causes marked distress not be better accounted for by another mental disorder, a drug (legal or illegal), or some other medical condition. A person with HSDD will not start or respond to their partner's desire for sexual activity.
The female hypoactive sexual desire disorder therapeutics market…
LATAM Hypoactive Sexual Desire Disorder Treatment Market Report 2020-2027
According to a new report published by Report Ocean, titled, "LATAM hypoactive sexual desire disorder treatment market by Treatment Type and Sales Channel: Regional Opportunity Analysis and Industry Forecast, 2019–2027," the LATAM hypoactive sexual desire disorder treatment market size was valued at $967million in 2019, and is expected to reach $1,275 million by 2027, registering a CAGR of 6.1% from 2019 to 2027.
GET SAMPLE PAGES @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1315
Hypoactive sexual desire…
Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, Demand and SW …
The report aims to provide an overview of in female hypoactive sexual desire disorder therapeutics market with detailed market segmentation by therapy and application. The female hypoactive sexual desire disorder therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in female hypoactive sexual desire disorder therapeutics market players and offers key trends and opportunities in…